Silvia Hummel BSc (Birmingham), MSc (Lancaster)
Research Fellow in Healthcare Modelling
Address:
HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield S1 4DA
Tel: (+44) (0)114 222 1728
Fax: (44) (0) 114 272 4095
E-mail: s.hummel@sheffield.ac.uk
Room: 2004
Biography
I am a Research Fellow in the Health Economics and Decision Science (HEDS) section of the School of Health and Related Research (ScHARR). I am an operational research analyst with several years experience of mathematical modelling in health. I have led applied research and consultancy studies for both private and public healthcare clients including the NICE technology appraisal and public health health programmes. I joined ScHARR in 2000, having formally been at the York Health Economics Consortium, University of York. Between 2002 and 2006 I lived in Montreal, Canada working with Soldage, a joint University of Montreal - McGill University collaborative research group on frailty and ageing.
Research Interests
- Cost-effectiveness modelling
- Economic evaluation of cancer treatments
- Prostate and lung cancer
- Modelling the consequences of public health interventions
Teaching Interests
- Joint module co-ordinator for "Cost-effectiveness modelling for health technology assessment".
Current Projects
- Assessment of clinical and cost-effectiveness of IMRT for prostate cancer
- Assessment of screening for prostate cancer
- Modelling the long term outcomes of interventions to promote the social and emotional wellbeing of vulnerable pre-school children
Key publications
- Intensity modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technology Assessment 2010 (in press).
- Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review. Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, Hamdy F, Clarke N, Staffurth J. Health Technology Assessment 2009;13(5)
- Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. Hummel S, Paisley S, Morgan A, Currie E, Brewer N. Health Technology Assessment 2003;7(33)
- Frailty, an emerging research and clinical paradigm: issues and contraversies. Bergman H, Gerrucci L, Guralnik J, Hogan D, Hummel S, Karunanthan K, Wolfson C. J Gerontol A Biol Sci Med Sci 2007 Jul; 62(7):731-7.
- Methodological issues in the economic analysis of cancer treatments. Tappenden P, Chilcott J, Ward S, Eggington S, Hind D, Hummel S. Eur J Cancer 2006 Nov;42(17):2867-75